Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG
Clinical trial NCT01390402 · COMPLETED
Trial details
- NCT number
- NCT01390402
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2014-11-01
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.